Song Jun, Yang Dongshan, Xu Jie, Zhu Tianqing, Chen Y Eugene, Zhang Jifeng
Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
Nat Commun. 2016 Jan 28;7:10548. doi: 10.1038/ncomms10548.
Zinc-finger nuclease, transcription activator-like effector nuclease and CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) are becoming major tools for genome editing. Importantly, knock-in in several non-rodent species has been finally achieved thanks to these customizable nucleases; yet the rates remain to be further improved. We hypothesize that inhibiting non-homologous end joining (NHEJ) or enhancing homology-directed repair (HDR) will improve the nuclease-mediated knock-in efficiency. Here we show that the in vitro application of an HDR enhancer, RS-1, increases the knock-in efficiency by two- to five-fold at different loci, whereas NHEJ inhibitor SCR7 has minimal effects. We then apply RS-1 for animal production and have achieved multifold improvement on the knock-in rates as well. Our work presents tools to nuclease-mediated knock-in animal production, and sheds light on improving gene-targeting efficiencies on pluripotent stem cells.
锌指核酸酶、转录激活样效应因子核酸酶以及CRISPR(规律成簇间隔短回文重复序列)/Cas9(CRISPR相关蛋白9)正成为基因组编辑的主要工具。重要的是,多亏了这些可定制的核酸酶,终于在几种非啮齿类动物中实现了基因敲入;然而其效率仍有待进一步提高。我们推测抑制非同源末端连接(NHEJ)或增强同源定向修复(HDR)将提高核酸酶介导的基因敲入效率。在此我们表明,体外应用一种HDR增强剂RS-1可使不同位点的基因敲入效率提高两到五倍,而NHEJ抑制剂SCR7的作用极小。然后我们将RS-1应用于动物生产,并在基因敲入率方面也实现了成倍提高。我们的工作为核酸酶介导的基因敲入动物生产提供了工具,并为提高多能干细胞的基因靶向效率提供了思路。